"Designing Growth Strategies is in our DNA"

Amyotrophic Lateral Sclerosis Therapeutics Market Size, Share & Industry Analysis, By Drug Type (Tofersen, Edaravone, Riluzole, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI110139

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Epidemiology of Amyotrophic Lateral Sclerosis - by Key Countries/Regions, 2023
    2. Pipeline Analysis – by Key Companies
    3. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
    4. Impact of COVID-19 on the Market
  5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Tofersen
      2. Edaravone
      3. Riluzole
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Amyotrophic Lateral Sclerosis Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Tofersen
      2. Edaravone
      3. Riluzole
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Tofersen
      2. Edaravone
      3. Riluzole
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Tofersen
      2. Edaravone
      3. Riluzole
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. Australia
      4. India
      5. Rest of Asia Pacific
  9. Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Type
      1. Tofersen
      2. Edaravone
      3. Riluzole
      4. Others
    2. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail & Online Pharmacy
  10. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. Biogen
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Mitsubishi Tanabe Pharma
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Sanofi
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. EDW Pharma, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Aquestive Therapeutics
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Otsuka Pharmaceutical, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Novartis Pharmaceuticals
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Zydus Lifesciences Limited
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Clene Nanomedicine
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Annexon, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue Breakdown (USD billion, %) by Region, 2019 & 2032

Figure 2: Global Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Drug Type, 2019 & 2032

Figure 3: Global Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Route of Administration, 2019 & 2032

Figure 4: Global Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Distribution Channel, 2019 & 2032

Figure 5: Global Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Region, 2019 & 2032

Figure 6: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Drug Type, 2019 & 2032

Figure 7: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Drug Type, 2023

Figure 8: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Route of Administration, 2019 & 2032

Figure 9: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Route of Administration, 2023

Figure 10: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2032

Figure 11: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Distribution Channel, 2023

Figure 12: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), By Country, 2019 & 2032

Figure 13: North America Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), By Country, 2023

Figure 14: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Drug Type, 2019 & 2032

Figure 15: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Drug Type, 2023

Figure 16: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Route of Administration, 2019 & 2032

Figure 17: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Route of Administration, 2023

Figure 18: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2032

Figure 19: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Distribution Channel, 2023

Figure 20: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2032

Figure 21: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), By Country/ Sub-region, 2023

Figure 22: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Drug Type, 2019 & 2032

Figure 23: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Drug Type, 2023

Figure 24: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Route of Administration, 2019 & 2032

Figure 25: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Route of Administration, 2023

Figure 26: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2032

Figure 27: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Distribution Channel, 2023

Figure 28: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), By Country/ Sub-region, 2019 & 2032

Figure 29: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), By Country/ Sub-region, 2023

Figure 30: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Drug Type, 2019 & 2032

Figure 31: Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Drug Type, 2023

Figure 32: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Route of Administration, 2019 & 2032

Figure 33: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Route of Administration, 2023

Figure 34: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Value (USD billion), by Distribution Channel, 2019 & 2032

Figure 35: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Value Share (%), by Distribution Channel, 2023

Figure 36: Global Amyotrophic Lateral Sclerosis Therapeutics Market Share (%), By Company, 2023

Table 1: Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032

Table 2: Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 3: Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 4: Global Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032

Table 6: North America Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 7: North America Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 8: North America Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032

Table 10: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 11: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 12: Europe Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032

Table 14: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 15: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 16: Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032

Table 18: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 19: Rest of the World Amyotrophic Lateral Sclerosis Therapeutics Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032a

Amyotrophic Lateral Sclerosis Therapeutics Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 100
Consulting Services
    How will you benefit from our consulting services ?